Artificial intelligence (AI) is significantly transforming the pharmaceutical industry by enhancing various aspects of drug discovery and development. Traditionally, bringing a new drug to market has been an arduous, costly, and time-consuming process, often taking more than a decade and requiring billions of dollars in investment. The high failure rate of drug candidates, coupled with […]

Earlier this month, a Texas judge granted an injunction to halt a New York doctor, Margaret Daley Carpenter, from prescribing and sending medication abortion pills to patients in Texas and imposed a $100,000 fine. The case is the first known to openly challenge an abortion shield law, passed by eighteen states and the […]

Considering recent declines in research grants, the federal scientific workforce, and public access to research, the future of medical innovation is uncertain. However, even before these challenges arose, there were already parts of the system that limited progress.  One problem is that pharmaceutical patents held by large drug manufacturers limit generic drug production. […]

Telehealth, health care through technological services, has been an increasingly used form of care since the COVID-19 pandemic when digital health care became increasingly necessary to limit in-person interactions. Telehealth is conducted completely online and, therefore, has the potential to be revolutionary for disabled folks who would benefit from the convenience of a digital platform. […]

Health inequities affecting people with disabilities remain a persistent and often overlooked issue within the U.S. healthcare system. Despite efforts to make healthcare more inclusive, provider biases and financial challenges continue to prevent millions from receiving equitable care. With recent policy pushes for broader health equity, now is the time […]